✦ LIBER ✦

Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

✍ Scribed by Paul J. Goodnick; Cecilia A. Jorge; Thomas Hunter; Adarsh M. Kumar

Book ID: 110272254
Publisher: American Academy of Clinical Psychiatrists
Year: 2000
Tongue: English
Weight: 40 KB
Volume: 12
Category: Article
ISSN: 1040-1237
DOI: 10.1023/a:1009024214337

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Somatization Disorder with

Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

✍ Matthew Menza; Marc Lauritano; Lesley Allen; Melissa Warman; Frank Ostella; Robe 📂 Article 📅 2001 🏛 American Academy of Clinical Psychiatrists 🌐 English ⚖ 54 KB

Pilot open-label study of nefazodone in

Pilot open-label study of nefazodone in panic disorder

✍ Alexander Bystritsky; Richard Rosen; Rita Suri; Tanya Vapnik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Ten patients meeting DSM-IV criteria for non-comorbid panic disorder or panic disorder with agoraphobia were treated in a 12-week open-label, flexible dosage trial of nefazodone. Dosages ranged from 50 to 400 mg per day. Clinical assessment utilized several recently developed scales of panic disorde

An open-label study of escitalopram (Lex

An open-label study of escitalopram (Lexapro®) for the treatment of ‘Depression of Alzheimer's disease’ (dAD)

✍ V. Rao; J. R. Spiro; P. B. Rosenberg; H. B. Lee; A. Rosenblatt; C. G. Lyketsos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract ## Background Depression is a frequent neuropsychiatric complication of Alzheimer's Disease. ## Methods This study investigated the safety and effectiveness of escitalopram (LEXAPRO) for depression in AD (dAD) as defined by the NIMH consensus criteria in an 8‐week, open‐label treatme

Effectiveness and tolerability of citalo

Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

✍ Shella Schirman; Sefi Kronenberg; Alan Apter; David Brent; Nadine Melhem; Nimrod 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 176 KB

Paroxetine in the treatment of depressed

Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study

✍ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a

Preliminary Results of an Open Label Stu

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

✍ Maria Katsamanis Karavidas; Paul M. Lehrer; Evgeny Vaschillo; Bronya Vaschillo; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 334 KB